Report Cover

Global mRNA Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026


The mRNA Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global mRNA Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global mRNA Treatment market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
mRNA Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Vaccine
    Drugs

Market segment by Application, can be divided into
    Protein Diseases
    Gene Dysfunction Diseases
    Others

Market segment by players, this report covers
    CureVac
    Moderna
    BioNTech (Pfizer)
    Sanofi (Translate Bio)
    Ethris (AstraZeneca)
    Kernal Biologics
    RaNA Therapeutics
    Silence Therapeutics

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
    1.1 Product Overview and Scope of mRNA Treatment
    1.2 Classification of mRNA Treatment by Type
        1.2.1 Overview: Global mRNA Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global mRNA Treatment Revenue Market Share by Type in 2020
        1.2.3 Vaccine
        1.2.4 Drugs
    1.3 Global mRNA Treatment Market by Application
        1.3.1 Overview: Global mRNA Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Protein Diseases
        1.3.3 Gene Dysfunction Diseases
        1.3.4 Others
    1.4 Global mRNA Treatment Market Size & Forecast
    1.5 Global mRNA Treatment Market Size and Forecast by Region
        1.5.1 Global mRNA Treatment Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global mRNA Treatment Market Size by Region, (2016-2021)
        1.5.3 North America mRNA Treatment Market Size and Prospect (2016-2026)
        1.5.4 Europe mRNA Treatment Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific mRNA Treatment Market Size and Prospect (2016-2026)
        1.5.6 South America mRNA Treatment Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa mRNA Treatment Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 mRNA Treatment Market Drivers
        1.6.2 mRNA Treatment Market Restraints
        1.6.3 mRNA Treatment Trends Analysis
2 Company Profiles
    2.1 CureVac
        2.1.1 CureVac Details
        2.1.2 CureVac Major Business
        2.1.3 CureVac mRNA Treatment Product and Solutions
        2.1.4 CureVac mRNA Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 CureVac Recent Developments and Future Plans
    2.2 Moderna
        2.2.1 Moderna Details
        2.2.2 Moderna Major Business
        2.2.3 Moderna mRNA Treatment Product and Solutions
        2.2.4 Moderna mRNA Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Moderna Recent Developments and Future Plans
    2.3 BioNTech (Pfizer)
        2.3.1 BioNTech (Pfizer) Details
        2.3.2 BioNTech (Pfizer) Major Business
        2.3.3 BioNTech (Pfizer) mRNA Treatment Product and Solutions
        2.3.4 BioNTech (Pfizer) mRNA Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 BioNTech (Pfizer) Recent Developments and Future Plans
    2.4 Sanofi (Translate Bio)
        2.4.1 Sanofi (Translate Bio) Details
        2.4.2 Sanofi (Translate Bio) Major Business
        2.4.3 Sanofi (Translate Bio) mRNA Treatment Product and Solutions
        2.4.4 Sanofi (Translate Bio) mRNA Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Sanofi (Translate Bio) Recent Developments and Future Plans
    2.5 Ethris (AstraZeneca)
        2.5.1 Ethris (AstraZeneca) Details
        2.5.2 Ethris (AstraZeneca) Major Business
        2.5.3 Ethris (AstraZeneca) mRNA Treatment Product and Solutions
        2.5.4 Ethris (AstraZeneca) mRNA Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Ethris (AstraZeneca) Recent Developments and Future Plans
    2.6 Kernal Biologics
        2.6.1 Kernal Biologics Details
        2.6.2 Kernal Biologics Major Business
        2.6.3 Kernal Biologics mRNA Treatment Product and Solutions
        2.6.4 Kernal Biologics mRNA Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Kernal Biologics Recent Developments and Future Plans
    2.7 RaNA Therapeutics
        2.7.1 RaNA Therapeutics Details
        2.7.2 RaNA Therapeutics Major Business
        2.7.3 RaNA Therapeutics mRNA Treatment Product and Solutions
        2.7.4 RaNA Therapeutics mRNA Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 RaNA Therapeutics Recent Developments and Future Plans
    2.8 Silence Therapeutics
        2.8.1 Silence Therapeutics Details
        2.8.2 Silence Therapeutics Major Business
        2.8.3 Silence Therapeutics mRNA Treatment Product and Solutions
        2.8.4 Silence Therapeutics mRNA Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Silence Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global mRNA Treatment Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 mRNA Treatment Players Market Share
        3.2.2 Top 10 mRNA Treatment Players Market Share
        3.2.3 Market Competition Trend
    3.3 mRNA Treatment Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global mRNA Treatment Revenue and Market Share by Type (2016-2021)
    4.2 Global mRNA Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global mRNA Treatment Revenue Market Share by Application (2016-2021)
    5.2 mRNA Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America mRNA Treatment Revenue by Type (2016-2026)
    6.2 North America mRNA Treatment Revenue by Application (2016-2026)
    6.3 North America mRNA Treatment Market Size by Country
        6.3.1 North America mRNA Treatment Revenue by Country (2016-2026)
        6.3.2 United States mRNA Treatment Market Size and Forecast (2016-2026)
        6.3.3 Canada mRNA Treatment Market Size and Forecast (2016-2026)
        6.3.4 Mexico mRNA Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe mRNA Treatment Revenue by Type (2016-2026)
    7.2 Europe mRNA Treatment Revenue by Application (2016-2026)
    7.3 Europe mRNA Treatment Market Size by Country
        7.3.1 Europe mRNA Treatment Revenue by Country (2016-2026)
        7.3.2 Germany mRNA Treatment Market Size and Forecast (2016-2026)
        7.3.3 France mRNA Treatment Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom mRNA Treatment Market Size and Forecast (2016-2026)
        7.3.5 Russia mRNA Treatment Market Size and Forecast (2016-2026)
        7.3.6 Italy mRNA Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific mRNA Treatment Revenue by Type (2016-2026)
    8.2 Asia-Pacific mRNA Treatment Revenue by Application (2016-2026)
    8.3 Asia-Pacific mRNA Treatment Market Size by Region
        8.3.1 Asia-Pacific mRNA Treatment Revenue by Region (2016-2026)
        8.3.2 China mRNA Treatment Market Size and Forecast (2016-2026)
        8.3.3 Japan mRNA Treatment Market Size and Forecast (2016-2026)
        8.3.4 South Korea mRNA Treatment Market Size and Forecast (2016-2026)
        8.3.5 India mRNA Treatment Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia mRNA Treatment Market Size and Forecast (2016-2026)
        8.3.7 Australia mRNA Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America mRNA Treatment Revenue by Type (2016-2026)
    9.2 South America mRNA Treatment Revenue by Application (2016-2026)
    9.3 South America mRNA Treatment Market Size by Country
        9.3.1 South America mRNA Treatment Revenue by Country (2016-2026)
        9.3.2 Brazil mRNA Treatment Market Size and Forecast (2016-2026)
        9.3.3 Argentina mRNA Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa mRNA Treatment Revenue by Type (2016-2026)
    10.2 Middle East & Africa mRNA Treatment Revenue by Application (2016-2026)
    10.3 Middle East & Africa mRNA Treatment Market Size by Country
        10.3.1 Middle East & Africa mRNA Treatment Revenue by Country (2016-2026)
        10.3.2 Turkey mRNA Treatment Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia mRNA Treatment Market Size and Forecast (2016-2026)
        10.3.4 UAE mRNA Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global mRNA Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026 Table 2. Global mRNA Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026 Table 3. Global Market mRNA Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026) Table 4. Global mRNA Treatment Revenue (USD Million) by Region (2016-2021) Table 5. Global mRNA Treatment Revenue Market Share by Region (2021-2026) Table 6. CureVac Corporate Information, Head Office, and Major Competitors Table 7. CureVac Major Business Table 8. CureVac mRNA Treatment Product and Solutions Table 9. CureVac mRNA Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 10. Moderna Corporate Information, Head Office, and Major Competitors Table 11. Moderna Major Business Table 12. Moderna mRNA Treatment Product and Solutions Table 13. Moderna mRNA Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 14. BioNTech (Pfizer) Corporate Information, Head Office, and Major Competitors Table 15. BioNTech (Pfizer) Major Business Table 16. BioNTech (Pfizer) mRNA Treatment Product and Solutions Table 17. BioNTech (Pfizer) mRNA Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 18. Sanofi (Translate Bio) Corporate Information, Head Office, and Major Competitors Table 19. Sanofi (Translate Bio) Major Business Table 20. Sanofi (Translate Bio) mRNA Treatment Product and Solutions Table 21. Sanofi (Translate Bio) mRNA Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 22. Ethris (AstraZeneca) Corporate Information, Head Office, and Major Competitors Table 23. Ethris (AstraZeneca) Major Business Table 24. Ethris (AstraZeneca) mRNA Treatment Product and Solutions Table 25. Ethris (AstraZeneca) mRNA Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 26. Kernal Biologics Corporate Information, Head Office, and Major Competitors Table 27. Kernal Biologics Major Business Table 28. Kernal Biologics mRNA Treatment Product and Solutions Table 29. Kernal Biologics mRNA Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 30. RaNA Therapeutics Corporate Information, Head Office, and Major Competitors Table 31. RaNA Therapeutics Major Business Table 32. RaNA Therapeutics mRNA Treatment Product and Solutions Table 33. RaNA Therapeutics mRNA Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 34. Silence Therapeutics Corporate Information, Head Office, and Major Competitors Table 35. Silence Therapeutics Major Business Table 36. Silence Therapeutics mRNA Treatment Product and Solutions Table 37. Silence Therapeutics mRNA Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 38. Global mRNA Treatment Revenue (USD Million) by Players (2019-2021) Table 39. Global mRNA Treatment Revenue Share by Players (2019-2021) Table 40. Breakdown of mRNA Treatment by Company Type (Tier 1, Tier 2 and Tier 3) Table 41. mRNA Treatment Players Head Office, Products and Services Provided Table 42. mRNA Treatment Mergers & Acquisitions in the Past Five Years Table 43. mRNA Treatment New Entrants and Expansion Plans Table 44. Global mRNA Treatment Revenue (USD Million) by Type (2016-2021) Table 45. Global mRNA Treatment Revenue Share by Type (2016-2021) Table 46. Global mRNA Treatment Revenue Forecast by Type (2021-2026) Table 47. Global mRNA Treatment Revenue by Application (2016-2021) Table 48. Global mRNA Treatment Revenue Forecast by Application (2021-2026) Table 49. North America mRNA Treatment Revenue by Type (2016-2021) & (USD Million) Table 50. North America mRNA Treatment Revenue by Type (2021-2026) & (USD Million) Table 51. North America mRNA Treatment Revenue by Application (2016-2021) & (USD Million) Table 52. North America mRNA Treatment Revenue by Application (2021-2026) & (USD Million) Table 53. North America mRNA Treatment Revenue by Country (2016-2021) & (USD Million) Table 54. North America mRNA Treatment Revenue by Country (2021-2026) & (USD Million) Table 55. Europe mRNA Treatment Revenue by Type (2016-2021) & (USD Million) Table 56. Europe mRNA Treatment Revenue by Type (2021-2026) & (USD Million) Table 57. Europe mRNA Treatment Revenue by Application (2016-2021) & (USD Million) Table 58. Europe mRNA Treatment Revenue by Application (2021-2026) & (USD Million) Table 59. Europe mRNA Treatment Revenue by Country (2016-2021) & (USD Million) Table 60. Europe mRNA Treatment Revenue by Country (2021-2026) & (USD Million) Table 61. Asia-Pacific mRNA Treatment Revenue by Type (2016-2021) & (USD Million) Table 62. Asia-Pacific mRNA Treatment Revenue by Type (2021-2026) & (USD Million) Table 63. Asia-Pacific mRNA Treatment Revenue by Application (2016-2021) & (USD Million) Table 64. Asia-Pacific mRNA Treatment Revenue by Application (2021-2026) & (USD Million) Table 65. Asia-Pacific mRNA Treatment Revenue by Region (2016-2021) & (USD Million) Table 66. Asia-Pacific mRNA Treatment Revenue by Region (2021-2026) & (USD Million) Table 67. South America mRNA Treatment Revenue by Type (2016-2021) & (USD Million) Table 68. South America mRNA Treatment Revenue by Type (2021-2026) & (USD Million) Table 69. South America mRNA Treatment Revenue by Application (2016-2021) & (USD Million) Table 70. South America mRNA Treatment Revenue by Application (2021-2026) & (USD Million) Table 71. South America mRNA Treatment Revenue by Country (2016-2021) & (USD Million) Table 72. South America mRNA Treatment Revenue by Country (2021-2026) & (USD Million) Table 73. Middle East & Africa mRNA Treatment Revenue by Type (2016-2021) & (USD Million) Table 74. Middle East & Africa mRNA Treatment Revenue by Type (2021-2026) & (USD Million) Table 75. Middle East & Africa mRNA Treatment Revenue by Application (2016-2021) & (USD Million) Table 76. Middle East & Africa mRNA Treatment Revenue by Application (2021-2026) & (USD Million) Table 77. Middle East & Africa mRNA Treatment Revenue by Country (2016-2021) & (USD Million) Table 78. Middle East & Africa mRNA Treatment Revenue by Country (2021-2026) & (USD Million) List of Figures Figure 1. mRNA Treatment Picture Figure 2. Global mRNA Treatment Revenue Market Share by Type in 2020 Figure 3. Vaccine Figure 4. Drugs Figure 5. mRNA Treatment Revenue Market Share by Application in 2020 Figure 6. Protein Diseases Picture Figure 7. Gene Dysfunction Diseases Picture Figure 8. Others Picture Figure 9. Global mRNA Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026 Figure 10. Global mRNA Treatment Revenue and Forecast (2016-2026) & (USD Million) Figure 11. Global mRNA Treatment Revenue Market Share by Region (2016-2026) Figure 12. Global mRNA Treatment Revenue Market Share by Region in 2020 Figure 13. North America mRNA Treatment Revenue (USD Million) and Growth Rate (2016-2026) Figure 14. Europe mRNA Treatment Revenue (USD Million) and Growth Rate (2016-2026) Figure 15. Asia-Pacific mRNA Treatment Revenue (USD Million) and Growth Rate (2016-2026) Figure 16. South America mRNA Treatment Revenue (USD Million) and Growth Rate (2016-2026) Figure 17. Middle East and Africa mRNA Treatment Revenue (USD Million) and Growth Rate (2016-2026) Figure 18. mRNA Treatment Market Drivers Figure 19. mRNA Treatment Market Restraints Figure 20. mRNA Treatment Market Trends Figure 21. CureVac Recent Developments and Future Plans Figure 22. Moderna Recent Developments and Future Plans Figure 23. BioNTech (Pfizer) Recent Developments and Future Plans Figure 24. Sanofi (Translate Bio) Recent Developments and Future Plans Figure 25. Ethris (AstraZeneca) Recent Developments and Future Plans Figure 26. Kernal Biologics Recent Developments and Future Plans Figure 27. RaNA Therapeutics Recent Developments and Future Plans Figure 28. Silence Therapeutics Recent Developments and Future Plans Figure 29. Global mRNA Treatment Revenue Share by Players in 2020 Figure 30. mRNA Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure 31. Global Top 3 Players mRNA Treatment Revenue Market Share in 2020 Figure 32. Global Top 10 Players mRNA Treatment Revenue Market Share in 2020 Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021) Figure 34. Global mRNA Treatment Revenue Share by Type in 2020 Figure 35. Global mRNA Treatment Market Share Forecast by Type (2021-2026) Figure 36. Global mRNA Treatment Revenue Share by Application in 2020 Figure 37. Global mRNA Treatment Market Share Forecast by Application (2021-2026) Figure 38. North America mRNA Treatment Sales Market Share by Type (2016-2026) Figure 39. North America mRNA Treatment Sales Market Share by Application (2016-2026) Figure 40. North America mRNA Treatment Revenue Market Share by Country (2016-2026) Figure 41. United States mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 42. Canada mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 43. Mexico mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 44. Europe mRNA Treatment Sales Market Share by Type (2016-2026) Figure 45. Europe mRNA Treatment Sales Market Share by Application (2016-2026) Figure 46. Europe mRNA Treatment Revenue Market Share by Country (2016-2026) Figure 47. Germany mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 48. France mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 49. United Kingdom mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 50. Russia mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 51. Italy mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 52. Asia-Pacific mRNA Treatment Sales Market Share by Type (2016-2026) Figure 53. Asia-Pacific mRNA Treatment Sales Market Share by Application (2016-2026) Figure 54. Asia-Pacific mRNA Treatment Revenue Market Share by Region (2016-2026) Figure 55. China mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 56. Japan mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 57. South Korea mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 58. India mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 59. Southeast Asia mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 60. Australia mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 61. South America mRNA Treatment Sales Market Share by Type (2016-2026) Figure 62. South America mRNA Treatment Sales Market Share by Application (2016-2026) Figure 63. South America mRNA Treatment Revenue Market Share by Country (2016-2026) Figure 64. Brazil mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 65. Argentina mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 66. Middle East and Africa mRNA Treatment Sales Market Share by Type (2016-2026) Figure 67. Middle East and Africa mRNA Treatment Sales Market Share by Application (2016-2026) Figure 68. Middle East and Africa mRNA Treatment Revenue Market Share by Country (2016-2026) Figure 69. Turkey mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 70. Saudi Arabia mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 71. UAE mRNA Treatment Revenue and Growth Rate (2016-2026) & (USD Million) Figure 72. Methodology Figure 73. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us